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Evaluation of clonal relatedness of extended-spectrum 
P-lactamase-producing Proteus mirubilis isolates by 
quantitative antibiogram and RAPD typing 
Marie-Hilkne Nicolas-Chanoine and Florence Espinasse-Maes 
Department of Microbiology, Ambroise Par6 University Hospital, Boulogne, France 
Objective: To delineate, using two different typing systems, the clonal relatedness of 40 isolates of extended-spectrum 
P-lactamase (ESpla)-producing froteos mirabilis obtained over a period of 7 years in six hospitals in the Paris area and 
two in Pas-de-Calais. 
Methods: Random amplified polymorphic DNA (RAPD) polymerase chain reaction typing was applied by using three 
random primers on the ESpla-producing I? mirabilis isolates and on isogenic Escherichia coli strains with or without 
plasmids encoding the representative resistance pattern transferred from I? mirabilis. Quantitative antibiogram typing, 
which was also applied to the I? mirabilis isolates, was used to define the euclidean distance between these strains. 
Results: After having demonstrated that F! mirabilis plasmids did not influence chromosomal DNA amplification, we 
could classify the ESpla-producing I? mirabilis isolates into 12 groups based on RAPD fingerprints. The same isolates 
were classified into 19 groups by quantitative antibiogram typing. Despite this difference in group numbers, general 
concordance between the typing systems was observed. This allowed us to show that the greater number of isolates in 
some hospitals belonged to a single strain and that single isolates obtained in different hospitals generally represented 
unique strains. 
Conclusions: A small number of ESpla-producing I? mirabilis strains was isolated during 7 years in the eight medical 
centers studied, and the number of different strains identified suggested that inter-hospital transfer had not occurred. 
Key words: Extended-spectrum p-lactamase-producing F1 mirabilis, quantitative antibiogram typing system, arbitrarily 
primed PCR typing system 
INTRODUCTION 
Resistance to third-generation cephalosporins by 
production of extended-spectrum p-lactamases (ESpla) 
emerged in France in the mid-1980s in different 
enterobacterial species [l-51 but only at the end of that 
decade in Proteus mirabilis [6,7]. Moreover, the clinical 
occurrence of such P mirabilis isolates has remained 
rare since the appearance of the first strain in 1987 
in France. Therefore, we collected all the ESpla- 
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produiing l? mirabilis isolates kom 1987 to 1993 in 
different hospitals in the Paris area and in a hospital in 
Pas-de-Calais. Further strains which were isolated in 
a rehabilitation institute in Pas-de-Calais within a 3- 
month period in 1992 were .also included in the study. 
Since the transfer of patients between hospitals in the 
same area occurs kequently and could be a cause of the 
spread of ESpla-producing l? mirabilis, as was described 
for ESpla-producing Klebsiella pneumoniae [%lo], the 
goal of this study was to type all these isolates in order 
to delineate their clonal relatedness. 
Two typing systems were used, the phenotypic 
quantitative antibiogram method described by Blanc 
et al. [ll] and random amplified polymorphic DNA 
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(RAPD) fingerprinting [12]. The first method was 
chosen because it can be considered as a universal 
method, since any microbiological laboratory can apply 
it. The second one was chosen because it represents 
the most rapid method among the DNA-based typing 
systems and seems, according to the study of Bingen et 
al. [13], a promising method for I? mirabilis typing. 
Nevertheless, before applying RAPD fingerprinting 
to ESpla-producing I? mirabilis, we applied it to the 
Escherichia coli derivatives expressing the transferable 
antibiotic resistance patterns horn the I? mirabilis strains 
in order to confirm, as previously described [14,15], 
that the antibiotic resistance-encoding plasmids do not 
change the RAPD fingerprints of the isogenic plasmid- 
f?ee E. coli. 
MATERIALS AND METHODS 
Bacterial strains 
All consecutive but not repetitive ESPla-producing 
I? mirabilis isolates obtained between 1987 and 1993 in 
six Parisian hospitals (A, B, C, D, E and F) and a hospital 
in Pas-de-Cahs (G) were included. The five isolates 
(sl-5) whch were previously demonstrated as being 
responsible for an outbreak in hospid. B in 1989 [7] 
were used in this study as a reference set of epidemio- 
logically related strains. Thirteen further strains were 
provided by a rehabilitation institute (H) in Pas-de- 
Calais, in which an outbreak of infection by ESPla- 
producing I? mirabilis had been ongoing since November 
1992. For the hospitals where several strains were 
collected (A, n=13; B, n=8; C, n=2), the isolation 
dates and the wards in which the patients were situated 
are reported in Table 1. In each of the remaining 
hospitals, D, E, F and G, only one strain was isolated in 
1987, 1992, 1993 and 1989, respectively. 
E. coli J53-2 (F-, met F63, pro B22, nyR) was 
used as recipient in conjugation experiments, while E. 
coli MC-1061 [ r e d ,  hsdR mcrB araD 139 A(ara 
ABCleu)7679 mlac74 galU galK rpsL thQ] served for 
transformation by electroporation. 
Susceptibility testing 
Susceptibility to 22 antibiotics (amoxicillin, co-amoxi- 
clav, ticarcillin, cephalothin, cefamandole, cefoxitin, 
cefotaxime, ceftazidme, aztreonam, imipenem, kana- 
mycin, gentamicin, tobramycin, netilmicin, amikacin, 
chloramphenicol, tetracycline, fosfomycin, sulfa- 
methoxazole, trimethoprim, co-trimoxazole and 
pefloxacin) was determined by the disk difhsion agar 
method on Mueller-Hinton agar (bioMtrieux, Marcy 
l'Etoile, France) and interpreted in accordance with 
the recommendations of the Antibiogram Committee 
of the French Society for Microbiology [16]. As 
previously described, the production of ESpla was 
detected by the double disk synergy test [17]. 
Plasmid transfer 
Plasmid-mediated antibiotic resistance was transferred 
by conjugation experiments as previously described [7] 
or by electroporation according to standard procedure 
[l8]. E. coli derivatives were selected on agar contain- 
ing 150 mg/L ampicillin (Bristol-Myers-Squibb, Paris, 
France), 0.5 mg/L cefotaxime (Hoechst-Marion- 
Roussel, Paris, France) or 25 mg/L kanamycin (Sigma- 
Aldrich Chmie, Saint Quentin Fallavier, France). 
Table 1 Origin of 23 ESPla-producing isolates of I! mirabilk obtained in three hospitals in the Paris area (1987-1993) 
Hospital A Hospital B Hospital C 
Isolation Isolation Isolation 
Isolate Isolate Isolate 
number Ward Date' number Ward Date number Ward Date 
1 
2 
3 
4 
5 
6 
7 
8 
29 
91 
92 
93 
95 
icu 05.90 
icu 12.90 
icu 03.91 
icu 03.91 
icu 05.91 
icu 06.91 
reh 1 06.91 
icu 09.91 
Ped 03.93 
reh 2 06.93 
reh 2 07.93 
reh 2 08.93 
reh 2 09.93 
13 
s l  
s2 
s3 
s4 
s5 
15 
12 
icu 
icu 
icu 
icu 
icu 
icu 
ortho 
icu 
09.89 16 ortho 12.91 
11.89 30 orrho 03.93 
11.89 
11.89 
12.89 
12.89 
08.91 
08.91 
Abbreviation: icu=intensive care unit, ped=pediatrics, ortho=o&ope&cs, reh=rehabilitation unit 
'Month and year of strain isolation. 
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Rifampin (Hoechst-Marion-Roussel, Paris, France) at 
a concentration of 150 mg/L was added to the selecting 
medium in the conjugation experiments. 
Quantitative antibiogram typing 
Similarity analysis of the 40 ESPla-producing I? mirabilis 
strains was performed on the basis of the antibiotic 
susceptibility by using the euclidean distance. The 
antibiotics used in this analysis were those which 
showed the greatest variability of inhibition zone 
diameters and for which the resistance mechanisms 
were encoded by plasmid or chromosomal genes: 
cefotaxime, ceftazidime, gentamicin, amikacin, chloram- 
phenicol, trimethoprim and pefloxacin. The cut-off 
distance below which discrepancies were due to causal 
variability was calculated by measuring the inhibition 
zone diameters for each of the 40 strains on two 
different occasions. The cut-off distance was defined so 
that >95% of the distances between the first and the 
second determinations would be smaller than the cut- 
off distance. Thus, two isolates were considered to be 
different when the euclidean distance between them 
was hgher than the cut-off value. The algorithm used 
to produce a dendogram for antibiogram typing was 
the unweighted per group method [19]. 
Random amplified polymorphic DNA (RAPD) fingerprinting 
Bacteria were grown for 18 h on Columbia agar medium 
supplemented with 5% sheep blood. A colony was sus- 
pended in 0.5 mL of lysis buffer (20 mh4 Tris-HC1 (PH 
8.3) at 20"C, 50 mM KC1, 0.1% Tween-20), heated 
at 96°C for lornin, and then maintained at room 
temperature untd used in the reaction mixture. 
Three primers were used: AP4 (5'-TCAC- 
3') [20] and MHNl (5'-ACGTCTATGC-S'). The 
reaction mixture contained 10 mh4 Tris-HC1 @H 8.3), 
50 mM KC1, 2.5 mM MgCl2, 4 pmol/L of primer, 
400 pmol/L of each deoxynucleoside triphosphate 
(Pharmacia), 0.5 U of Tuq DNA polymerase (Perkin- 
Elmer-Cetus), and 1 pL of extract in lysis buffer in 
a final volume of 25 pL. Samples were subjected 
to 45 cycles in a GeneAmp PCR9600 thermal cycler 
(Perlun-Elmer) under the following conditions: de- 
naturation, 94°C for 15 s; annealing, 36OC for 15 s, 
extension, 72°C for 70 s. Final extension was 5 min at 
72 'C. Polymerase chain reaction (PCR) products were 
separated by electrophoresis in 1.5% agarose gels and 
stained with ethidium bromide. 
Two fingerprints were defined as different when 
they differed &om each other by at least a hgh-intensity 
band, or a low-intensity band which was reproducible 
in three independent amplification experiments. 
GATGCA-3') [12], HLWL74 (5'-ACGTATCTGC- 
RESULTS 
Antibiotic susceptibility of ESpla-producing I! mirabilis 
and their E, coli derivatives 
The 40 collected l? mirubilir isolates exhibited p-lactam 
susceptibility profdes consistent with the production of 
Table 2 Resistance patterns of E. coli derived h m  ESpla-producing I? mirabilis 
E. coli derivative 
Resistance markers Resistance 
Hospltal I? mirabilis isolate number co-transferred by conjugation pattern 
A 1 ,  2, 3, 4, 5, 6, 8, 29 ESpla/kgn/cmp/sulf I 
7 ESpla/kgtn/cmp/sulf/rmp/sxr I1 
92, 93, 95 ESpla/kma/sulf 111 
B s l ,  s2, s3, s4, s5, 15 ESpla/kma/sulf 111 
13 ESpla/kgt/sulf/tmp/sxt IV 
C 16 ESpla/kgtn/cmp/sulf I 
30 ESpla/kma/cmp/sulf/rmp/sxt V 
D 14 ESpla/kma/sulf/tec' VI 
E 17 ktna/cmp/sulf VII 
F 90 ESpla/kgm/sulf VIII 
H 18, 20, 31, 32, 33, 34, 36, 44 ESpla/kgm/suIf VIII 
91 No transfer 
12 No transfer 
G 89 No transfer 
19, 21, 22, 35, 45 ESpla/gtn/sulf/tmp/sxt IX 
Abbreviation: ESpla= extended-spectrum p-lactamase: a=amikacin, cmp=chloramphenicol; g= gentamicin, k=kanamycin; n=netilmicm; 
sulf=sulfarnethoxazole; sxt=co-trimoxazole; t=tobramycin; tet= tetracycline; tmp= trimethoprim. 
' E .  coli derivative obtained by electroporation. 
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ESpla: (1) decreased susceptibility or resistance to 
amoxicfin, ticarcillin, cephalothm, third-generation 
cephalosporins and aztreonam; (2) full susceptibdity to 
cefoxitin and imipenem, and (3) a positive disk synergy . 
test with a co-amoxiclav disk and third-generation 
cephalosporin disks. Except for strains 12 and 13, the 
inhibition zone diameters of cefotaxime were smaller 
than those of cefiazidime and aztreonam (data not 
shown). Different multiple aminogly coside resistance 
patterns were observed and each of them was 
transferable into E. coli when the mating experimend 
were successfbl (Table 2). All the l? mirubilis isolates 
were resistant to sulfimethoxazole but were distin- 
guished by different susceptibilities to chloram- 
phenicol, trimethoprim, co-trimoxazole, fosfomycin 
and pefloxacin (data not shown). The transferability of 
these drfferential antibiotic markers into E. coli is 
indicated in Table 2. The antibiotic resistance transfer 
fded  &om three ESpla-producing l? mirubilis isolates 
(12, 89 and 91) whichever transformation method or 
antibiotic selector (ampicillin, cefotaxime or kanamycin) 
was used. The transfer of the ESpla produced by l? 
mirubilis strain 17 was not successful, whereas that of 
other plasmid-mediated resistance markers was (Table 
2). Finally, nine transferable antibiotic resistance 
patterns were obtained in the 37 E. coli derivatives. 
The transfer &om 12 of the 13 ESpla-producing l? 
mirubilis strains isolated in hospital A resulted in three 
patterns (I, 11,111) in the E.  coli derivatives. Two of these 
three patterns were also observed in E .  coli derived &om 
P mirubilis isolated in other hospitals, namely pattern I11 
in E. coli strains derived h m  s ix  of the eight ES8la- 
producing l? mirubilis strains isolated in hospital B and 
pattern I in the E. coli strain derived h m  one of the 
two l? mirubilis strains isolated in hospital C .  From the 
13 l? mirubilis strains isolated in hospital H, two new 
different transferable resistance patterns, VIII and IX, 
were observed, but pattern VIII was also observed in 
the E. coli s t r a i n  derived &om the single l? mirabilis strain 
isolated in hospital E The four remaining patterns (IV, 
V, VI and VII) were each observed in E. coli strains 
derived from a single ESpla-producing l? mirabilis 
isolate. 
Quantitative antibiogram typing 
The determinations on two occasions of the antibiotic 
susceptibility of each ESpla-producing l? mirabilis 
isolate showed that the greatest euclidean distance was 
11.4, and 95.4% of the same isolates retested had a 
antibiogram typing classified the 40 ESpla-producing l? 
mirubilis isolates into 19 groups (Figure 1). 
The 13 strains isolated in hospital A between 1990 
and 1993 were classified into seven groups. According 
to the cut-off distance, seven of these strains (1,2,3,4,  
5 , 6  and 8) were found to be identical and constituted 
the first group. All these strains were isolated in the 
S R H  
T A 0  
R P S  
A D P  
Euclidean Distlna 
2 9 a  
45 b - 
35 b 
22 b 
36 b 
31 b 
21 b 
19 b 
4 4 b -  
8 9 d  G 
1 6 j  C 
1 k A  
17 a E 
M i  H 
14 I D 
difference of less than 11. Therefore, a cut-off at a 
distance of 11 was defined, above which discrepancies 
were considered as reflecting merences between 
the isolates. The dendogram based on the quantitative 
Figure 1 Dendogram of 40 ESPla-producing Proteus 
mirobilk isolates obtained by quantitative mtibiogram wing 
and heir M p D  fingerprin8. The hospitals where these 
strains were isolated are indicated in the right-hand lane. 
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same intensive care unit (ICU) but during a period 
of 16 months (Table 1). The second group, which 
included only one strain (29), was closely related to the 
first group. Each of the five remaining strains isolated 
in hospital A was placed in a specific group (Figure 1). 
The eight strains isolated in hospital B were 
classified into six new groups. The five s t r a i n s  (sl-5) 
previously described as being responsible for an 
outbreak in 1989 [7] in the ICU of this hospital were 
divided among four of the six groups but al l  four were 
closely related to each other. Strain 15, isolated in an 
orthopedic ward 8 months after the ICU outbreak, was 
found to be identical to strain s4. In contrast, although 
they were isolated in the ICU 2 months before and 8 
months after the outbreak, respectively, strains 12 and 
13 were placed in two merent groups showing great 
distances between them and the other groups (Figure 1). 
Two strains (16 and 30) isolated in hospital C, 
located in the Paris area, were placed in two different 
and new groups, but strain 16 was found to be identical 
to strain 89, which was the single strain isolated in 
hospital G, located in Pas-de-Calais. 
All but one (34) of the strains isolated within a 
short period in the rehabilitation institute in Pas-de- 
Calais were placed in a single and new group. 
Nevertheless, the one strain isolated in hospital F 
located in the Paris area was placed in this group. Strain 
34 constituted a new group, and the strains isolated in 
hospitals D and E also constituted two different new 
groups. 
RAPD fingerprints of E. coli derivatives and 
ESpla-producing I? mirabilis 
E .  coli J53-2, E. coli MC1601 and E. coli derivatives 
representative of the nine different transferable resis- 
tance patterns were submitted to RAPD finger- 
printing. As shown in Figure 2, no Merence could be 
observed with use of the primer HLWL74 between the 
RAPD fingerprints of both plasmid-fiee E. coli strains 
and the Merent E. coli derivatives. With use of the two 
other primers, AP4 and MHN1, identical results were 
obtained (data not shown). 
In contrast, the 40 ESpla-producing I? mirubifis 
isolates were classdied into six groups based on RAPD 
fingerprinting with the primer HLWL74, into eight 
with the primer AP4 and into 10 with the primer 
MHNl (Figure 3). After combining the fingerprints 
produced by each of the three primers for each strain, 
the 40 I? mirabilis strains were classified into 12 finger- 
printing profdes (Figure 1). Profile a was observed in 
Figure 2 RAPD fingerprints obtained with the primer HLWL74 of plasmid-&ee E. coli and isogenic E. coli derivatives 
harboring the plasmids encoding the nine representative transferable resistance patterns. Lane 1: E. coli J53-2. Lanes 2, 3, 4, 
5, 6, 7, 8, 9, 10 and 11: E. coli derived &om I! mirabilis 18, 19, s3, 15, 16, 1, 7, 13, 17 and 30 respectively. Lane 12: E. coli 
MC-1061. Lane 13: E. coli derived h m  I? mirubifis 14. Lane 14: negative control. M’, molecular weight marker. Molecular 
sizes are indicated in kb on the left. 
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Figure 3 RAPD fingerprints of 40 ESpla-producing I! mirubilis strains obtained with the primer MHNl. The strain 
number is indicated above. M and M’, molecular weight markers. Molecular sizes are indicated in kb on the left. T - , 
negative control. The same fingerprint was obtained with E! mirubilis 1, 2, 3, 4, 5, 6, 7, 8, 17, 29, sl, s2, s3, s4 and s5. 
Another fingerprint was shared by P mirubilis 91, 92, 95 and 15, and another by P mirubilis 89, 90, 18, 19, 20, 21, 22, 31, 
32, 33, 35, 36, 44 and 45. Strains 16, 30, 93, 15, 14, 34 and 13 each displayed a specific fingerprint. 
eight (1,2,3,4,5,6, 8 and 29) ofthe 13 strains isolated 
in hospital A, in strain 17 isolated in hospital E, and in 
the five strains (sl-5) responsible for an outbreak in 
hospital B. Profde b was found in all the strains isolated 
in the rehabilitation institute in Pas-de-Calais, in strain 
90 isolated in hospital F, and in two strains (91 and 
92) isolated in hospital A. Profde c was displayed by 
only one strain (15 in hospital B), while profile d was 
displayed by two strains, one (89) isolated in hospital G 
in Pas-de-Calais, and one (95) of the strains isolated in 
hospital A. The remaining profiles, e, f, g, h, i, j, k and 
1, were each observed in single strains: 93, 12, 13, 30, 
34, 16 and 7, respectively. 
DISCUSSION 
Clinical involvement of ESpla-producing P mirabifis has 
remained rare, in comparison with ESPla-producing 
K. pneumoniae [21,22]. This study shows that only one 
strain was isolated in four hospitals and two strains in 
two hospitals during the 7-year survey period. Never- 
theless, the clinical impact of such strains can be 
important locally, since 13 strains were found in 
hospital A and 13 others in the rehabihtation institute 
H. In the first case, these strains were isolated within a 
period of 4 years, whereas those in the second case 
occurred within 3 months, strongly suggesting the 
spread of an ESPla-producing P mirabilis strain in this 
institute. Despite an outbreak in 1989 including five 
strains previously demonstrated as epidemiologically 
and phenotypically related in hospital B [7], only 
sporadic isolations of other ESpla-producing P mirabilir 
strains were observed afterwards in this hospital. 
According to inhibition zone diameters of cefo- 
taxime, ceftazidime and aztreonam, the studied ESpla- 
producing l? mirubilis strains showed more commonly a 
cefotaximase than a ceftazidimase phenotype, as was the 
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case with the first ESpla identified in K. pneumoniae 
[1,3,17]. As observed in other enterobacterial species 
[2,4,5], the transferable plasmids encoding ESpla in l? 
mirabilis also encode multiple antibiotic resistance. 
Nevertheless, despite the use of selecting antibiotics 
corresponding to classical transferable antibiotic resist- 
ance markers, no E. coli derivatives were obtained from 
three ESpla-producing l? mirabilis isolates. This failure 
could be related to the low frequency of l? mirabilis 
plasmid transfer which has already been described for 
this species [7]. From another ESpla-producing I? 
mirabilis strain, no transconjugant could be selected on 
medium containing ampicillin or cefotaxime, whereas 
such could be selected on medium containing kana- 
mycin. Moreover, these transconjugants did not exhibit 
a p-lactam susceptibility profile consistent with the 
production of ESpla. This phenomenon might be due 
to the presence of a second non-motile and ESpla- 
encoding plasmid or to the localization of the ESpla- 
encoding gene on the chromosome, as was reported for 
TEM-12 in an E. coli strain [23]. 
To assess the clonal relatedness of the 40 ESpla- 
producing l? mirabilis isolates, we chose two typing 
systems so that the markers studied were totally 
merent. For the quantitative antibiogram typing, the 
marker consisted of the expression of chromosomal- or 
plasmid-mediated genes encoding antibiotic resistance. 
For the RAPD fingerprinting, the marker concerned 
the random amplification of chromosomal DNA frag- 
ments. We demonstrated that the DNA of the plasmids 
carried by ESpla-producing l? mirabilis isolates was not 
a template for the primers used, since an identical 
RAPD fingerprint was found for plasmid-fiee E. coli 
and E. coli derivatives harboring the transferable 
plasmids. Despite the ddference of the studied markers, 
the strain classifications obtained by the two typing 
systems appeared generally concordant. Indeed, the 
majority of the strains considered as identical by the 
euclidean distance method displayed the same RAPD 
fingerprint, and the strains showing the greatest 
distance between them displayed specific RAPD 
fingerprints. However, even with the use of three 
random primers, which increases the discriminatory 
power of RAPD fingerprinting, this method appears 
less discriminatory than the quantitative antibiogram 
typing system (12 fingerprints versus 19 groups). With 
the five ESpla-producing l? mirabilis isolates obtained 
over a period of 1 month in an ICU of hospital B, 
which were considered to result from the spread of a 
unique strain, according to the clinical epidemiologic 
data, the resistance phenotype, the plasmid content and 
the kinetic parameters of the ESpla produced [7], we 
found, in this study, that these strains were identical by 
the RAPD typing system but classified into four 
different, but closely related, groups by the quantitative 
antibiogram typing system. This observation suggests 
that a typing system based on the bacterial expression, 
such as antibiotic resistance, could be too sensitive in 
comparison with a typing system based on bacterial 
structure, such as chromosomal DNA. Indeed, quan- 
titative antibiogram typing identifies differences in 
isolates which belong to a same clone but are involved 
in an epidemic occurring over a relatively long period. 
On the other hand, the quantitative antibiogram typing 
system can be confusing, since it placed strains (s4 and 
15 or 89 and 16) in the same group, while the RAPD 
typing system distinguished them. Given the localiza- 
tion on plasmids of the majority of antibiotic resistance- 
encoding genes, two strains can be defined as identical 
by quantitative antibiogram typing because they carry 
the same plasmid, while being ddferent in the system 
of random chromosomal DNA amplification. This 
study also showed that strains which were placed into 
different and distant groups (91, 92 and all the strains 
isolated in the rehabilitation institute or 95 and 89, for 
example) could have the same RAPD fingerprint. This 
phenomenon might be consistent with the presence of 
different plasmids in the same strain. 
These observations emphasize the usefulness of 
using two different typing systems to analyze the clonal 
relatedness of strains. Applying this approach in this 
study, we showed that all but one of the strains isolated 
in the rehabilitation institute in Pas-de-Calais were 
identical. The single strain isolated in hospital G, also 
located in Pas-de-Calais, was different &om the strains 
isolated in the rehabilitation institute. In contrast, the 
single strain isolated in 1993 in hospital F located in the 
Paris area was found by both typing systems to be 
identical to the epidemic strain in the rehabilitation 
institute. This finding is interesting but not surprising, 
because patient transfer fiom rehabilitation institutes to 
hospitals is common. Nevertheless, this strain was not 
responsible for any epidemic spread in hospital E 
In hospitals A and B, a similar situation was 
observed, namely the presence of an epidemic strain, 
and the presence of sporadic strains. Interestingly, both 
epidemic strains displayed the same RAPD fingerprint 
and this could suggest an association with epidemic 
potential. The single strains isolated in the other 
hospitals appear unique by both typing systems. This 
was notably the case with the first strain (14) of ESpla- 
producing l? mirubifis isolated in France. 
In conclusion, when a number of ESpla-producing 
l? mirabilis isolates were obtained in a single hospital 
during the 7-year survey, these isolations represented 
essentially the spread of a same strain, whereas when 
a single or few isolates were obtained, these isolates 
each represented a unique strain. Thus, the transfer of 
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ESpla-producing I? mirabilis strains between hospitals 
does not appear to be common. 
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